Avita Medical Inc Expected To Post A Loss Of 38 Cents A Share: Earnings Preview

AVITA Medical

07/05/2025 24:13

AVITA Medical Inc RCEL.OQ RCEL.O is expected to show a rise in quarterly revenue when it reports  results on May 8 for the period ending March 31 2025

The Valencia California California-based  company is expected to report a 90.4% increase in revenue to $21.142 million from $11.1 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.

​LSEG's mean analyst estimate for AVITA Medical Inc is for a loss of 38 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for AVITA Medical Inc is $17.00​, above​ its last closing price of $9.21. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.49
-0.43
-0.44
Missed
-1.6
Sep. 30 2024
-0.44
-0.44
-0.62
Missed
-42.1
Jun. 30 2024
-0.52
-0.52
-0.60
Missed
-15.8​
Mar. 31 2024
-0.45
-0.47
-0.73
Missed
-54.3
​​Dec. 31 2023
-0.36
-0.37
-0.28
Beat
25.2
Sep. 30 2023
-0.45
-0.44
-0.34
Beat
23.4​
Jun. 30 2023
-0.32
-0.32
-0.41
Missed
-26.4
Mar. 31 2023
-0.23
-0.25
-0.37
Missed
-47.4

This summary was machine generated May 6 at 23:13 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)